04/12/2021 |
General (Non-Research) |
In-kind items and services |
Education |
$10.87 |
Details |
Payment from |
Merck Sharp & Dohme Corporation |
Payment Record ID |
848493307 |
|
06/08/2021 |
Research |
In-kind items and services |
|
$940.00 |
Details |
Payment from |
PFIZER INC. |
Paymment Research Study |
ONCOLOGY PORTFOLIO CLINICAL PUBLICATION PROGRAM |
Payment Record ID |
832569451 |
|
02/12/2021 |
Research |
In-kind items and services |
|
$330.00 |
Details |
Payment from |
PFIZER INC. |
Paymment Research Study |
ONCOLOGY PORTFOLIO CLINICAL PUBLICATION PROGRAM |
Payment Record ID |
832500863 |
|
02/13/2020 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$156.89 |
Details |
Payment from |
PFIZER INC. |
Payment Record ID |
743808973 |
|
10/26/2018 |
General (Non-Research) |
Cash or cash equivalent |
Travel and Lodging |
$31.39 |
Details |
Payment from |
GENZYME CORPORATION |
Payment Record ID |
602934023 |
|
10/26/2018 |
General (Non-Research) |
Cash or cash equivalent |
Travel and Lodging |
$113.92 |
Details |
Payment from |
GENZYME CORPORATION |
Payment Record ID |
602933995 |
|
10/26/2018 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$207.35 |
Details |
Payment from |
GENZYME CORPORATION |
Payment Record ID |
602933131 |
|
03/06/2018 |
Research |
Cash or cash equivalent |
|
$7500.14 |
Details |
Payment from |
Eli Lilly and Company |
Paymment Research Study |
PHASE 1 STUDY TO IDENTIFY THE IMMUNOMODULATORY ACTIVITY OF LY3022855 IMC-CS4 IN PATIENTS WITH ADVANCED, REFRACTORY BREAST OR PROSTATE CANCER |
Clinical Trials Gov ID |
NCT02265536 |
Payment Record ID |
585603355 |
|
10/07/2017 |
General (Non-Research) |
Cash or cash equivalent |
Travel and Lodging |
$82.29 |
Details |
Payment from |
SANOFI-AVENTIS U.S. LLC |
Payment Record ID |
487770727 |
|
10/05/2017 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$71.28 |
Details |
Payment from |
SANOFI-AVENTIS U.S. LLC |
Payment Record ID |
487762117 |
|
10/07/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$136.89 |
Details |
Payment from |
SANOFI-AVENTIS U.S. LLC |
Payment Record ID |
487761155 |
|
10/04/2017 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$71.28 |
Details |
Payment from |
SANOFI-AVENTIS U.S. LLC |
Payment Record ID |
487754511 |
|
07/26/2017 |
Research |
In-kind items and services |
|
$890.00 |
Details |
Payment from |
Eli Lilly and Company |
Paymment Research Study |
PHASE 1 STUDY TO IDENTIFY THE IMMUNOMODULATORY ACTIVITY OF LY3022855 IMC-CS4 IN PATIENTS WITH ADVANCED, REFRACTORY BREAST OR PROSTATE CANCER |
Clinical Trials Gov ID |
NCT02265536 |
Payment Record ID |
457097575 |
|
01/07/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$127.12 |
Details |
Payment from |
Pfizer Inc. |
Payment Record ID |
403550316 |
|
10/26/2016 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$99.08 |
Details |
Payment from |
SANOFI-AVENTIS U.S. LLC |
Payment Record ID |
396864494 |
|
10/27/2016 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$99.08 |
Details |
Payment from |
SANOFI-AVENTIS U.S. LLC |
Payment Record ID |
394482363 |
|
11/15/2016 |
General (Non-Research) |
Cash or cash equivalent |
Travel and Lodging |
$175.24 |
Details |
Payment from |
SANOFI-AVENTIS U.S. LLC |
Payment Record ID |
394475696 |
|
11/15/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$319.72 |
Details |
Payment from |
SANOFI-AVENTIS U.S. LLC |
Payment Record ID |
394426907 |
|
10/28/2016 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$95.34 |
Details |
Payment from |
SANOFI-AVENTIS U.S. LLC |
Payment Record ID |
394418876 |
|
11/15/2016 |
General (Non-Research) |
Cash or cash equivalent |
Travel and Lodging |
$38.56 |
Details |
Payment from |
SANOFI-AVENTIS U.S. LLC |
Payment Record ID |
394398120 |
|
07/26/2016 |
Research |
In-kind items and services |
|
$2846.15 |
Details |
Payment from |
Eli Lilly and Company |
Paymment Research Study |
A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF LY2951742 IN PATIENTS WITH EPISODIC MIGRAINE - THE EVOLVE-1 STUDY |
Clinical Trials Gov ID |
NCT02614183 |
Payment Record ID |
372521136 |
|